Archives

  • Interim Report Q1, 2020

    CEO statementIt is a privilege for me today to present my first quarter and FRISQ’s second quarterly results for 2020. The ongoing pandemic has presented great challenges for a healthcare sector that, by necessity, has been forced to prioritize emergency care – repeatedly straining old-fashioned tools and methods to, and beyond, the limit – over improvements …

    More
  • Interim Report Q1, 2020

    Federal stamp of approval creates opportunities in a turbulent time. FRISQ – the only digital solution that meets the requirements for the patient contract CEO statementDuring the first three months of the year we conducted an over-subscribed preferential rights issue of approximately 74.6 MSEK, as well as many business development initiatives with customers in Sweden …

    More
No products in the cart.